Author

S. L. Goh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. Fridman· 1 shared A. S. Espeseth· 1 shared A. T. Gres· 1 shared C. Manfredi· 1 shared D. B. Olsen· 1 shared D. J. Hazuda· 1 shared D. Wang· 1 shared E. J. Sorscher· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Fridman

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Development of robust antiviral assays using relevant apical-out human airway organoids

J.-H. Lee, J. C. LeCher, E. Parigoris, N. Shinagawa, J. Sentosa, C. Manfredi, S. L. Goh, R. De, S. Tao, K. Zandi, F. Amblard, E. J. Sorscher, J. R. Spence, R. Tirouvanziam, R. F. Schinazi, S. Takayama

This paper develops AORBs, a high-throughput human airway organoid system, to robustly assess antiviral efficacy against SARS-CoV-2 with high throughput and clinical relevance.

bioRxiv · Jan 2, 2024 · PreprintBioengineering

The HIV-1 capsid core is an opportunistic nuclear import receptor

G. Xue, H. J. Yu, S. L. Goh, A. T. Gres, M. H. Guney, S. G. Sarafianos, J. Luban, V. N. KewalRamani

This study identifies HIV-1 capsid proteins as a nuclear import receptor that interacts with host nucleoporins and soluble factors to facilitate nuclear entry.

bioRxiv · Dec 2, 2021Cell Biology

Generation of a SARS-CoV-2 Replicon as a Model System to Dissect Virus Replication and Antiviral Inhibition

X. He, S. Quan, M. Xu, S. Rodriguez, S. L. Goh, J. Wei, A. Fridman, K. A. Koeplinger, S. S. Carroll, J. A. Grobler, A. S. Espeseth, D. B. Olsen, D. J. Hazuda, D. Wang

The paper develops a non-infectious SARS-CoV-2 replicon system to study viral replication and test antiviral compounds, revealing cell-line-specific inhibitor potencies.

bioRxiv · Dec 12, 2020 · PreprintMicrobiology